Brief: OptimizeRx fourth-quarter results beat estimates
12/03/2025 11:37
March 12 (Reuters) - OPTIMIZERx Corp OPRX.O: OPTIMIZERX Q4 GROSS PROFIT USD 22 MILLION OPTIMIZERX Q4 REVENUE USD 32.3 MILLION VERSUS. IBES ESTIMATE USD 30.4 MILLION OPTIMIZERX Q4 ADJUSTED NET INCOME USD 5.5 MILLION VERSUS. IBES ESTIMATE USD 5.07 MILLION OPTIMIZERX Q4 GROSS MARGIN 68% OPTIMIZERX Q4 ADJUSTED EBITDA USD 8.8 MILLION 2025 GUIDANCE: REVENUE EXPECTED TO BE AT LEAST $100 MILLION : QTRLY ADJUSTED EPS $0.30 Q4 EARNINGS PER SHARE VIEW $0.27 -- LSEG IBES DATA Source text: nGNXFTgKj Further company coverage: OPRX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on OptimizeRx
See all newsBrief: Optimizerx Announces Finance Leadership Appointments To Support The Next Phase Of Growth
OptimizeRx Corporation reports results for the quarter ended June 30 - Earnings Summary
OptimizeRx Q2 revenue beats estimates on operating resilience; reaffirms outlook
OptimizeRx Corporation expected to post earnings of 12 cents a share - Earnings Preview
Brief: Optimizerx Corp - Enters Credit Agreement With Fifth Third Bank On May 7, 2026 - SEC Filing